ArticleDiabetes therapy : research, treatment and education of diabetes and related disorders2020
Correction to: Optimising the Benefits of SGLT2 Inhibitors for Type 1 Diabetes.
Marc Evans et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.